Learn from peers, meet the makers, and help shape what’s next.
Join us for the 2026 QuartzBio Innovation Summit, an interactive experience designed to bring together industry leaders for meaningful conversations about the future of clinical trial data. Through expert-led sessions, peer discussions, and hands-on platform demonstrations, you will gain insights, influence innovation, and discover new opportunities to transform how sample, biomarker, and clinical data work together.
At the Summit, you’ll have the opportunity to:
- Explore emerging industry trends and challenges
- Connect with peers, experts, and industry leaders
- Discover new platform innovations and best practices
- Preview upcoming enhancements and roadmap priorities
- Share feedback that shapes future innovation
Accept Your Invitation:
Limited seats available — RSVP to reserve your spot. We'll send a confirmation email right away, followed by agenda details and reminder email closer to the date.Agenda:
| 1:30 PM – 1:35 PM | Welcome | Scott Marshall, PhD, CEO | Kickoff and overview of the day. |
| 1:35 PM – 2:15 PM |
Keynote: Biospecimen Quality, Data and AI in the Biomarker Era + Q&A with our Speaker | Brenda Yanak, Founder Clinical Transformation Partners and Industry Veteran in Biospecimen Management | Explore the regulatory and operational shifts driving the biospecimen and biomarker industry today and learn how companies are tackling it with AI. |
| 2:15 PM – 2:45 PM | Every Sample, Every Study, One Conversation: Virtual Biorepository, Portfolio Intelligence, and QuartzBio in Your AI Platform | Tobi Guennel, PhD, CTO | Learn about the newest areas of investment in the QuartzBio platform. |
| 2:45 PM – 3:30 PM | Break & Exploration Stations | All | Network with peers, see the QuartzBio platform in action, and enjoy drinks & light bites. |
| 3:30 PM – 4:10 PM | Roundtable I: From Fragmentation to Visibility — What Will it Take, and Can AI Solve It? | Tobi Guennel, PhD, CTO leads breakout roundtable group | An engaging discussion on data challenges, including site-to-sponsor fragmentation, multi-vendor complexity, disconnected operational data, and the ongoing struggle to identify risks before they become costly issues. |
| 4:10 PM – 4:50 PM | Roundtable II: Quality by Design Starts With the Sample — Breaking Down Departmental Silos for Sample Operations | Brenda Yanak leads breakout roundtable group | Explore how to bridge operational silos, closing gaps in sample integrity monitoring and improving trial outcomes. |
| 4:50 PM – 5:00 PM | Closing | Melinda Pautsch, CCO | Key takeaways and thanks |
| 5:15 PM | Depart for Dinner at Moxies Boston Seaport | All |
